5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide has been researched along with Diabetes Mellitus, Adult-Onset in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuccato, S; Ferrannini, E; Madec, S; Santini, E; Solini, A | 1 |
1 other study(ies) available for 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Effects of endothelin-1 on fibroblasts from type 2 diabetic patients: Possible role in wound healing and tissue repair.
Topics: Actins; Cells, Cultured; Chemokine CCL2; Dansyl Compounds; Diabetes Mellitus, Type 2; Endothelin A Receptor Antagonists; Endothelin-1; Female; Fibroblasts; Fibronectins; Humans; Interleukin-6; Laminin; Male; Middle Aged; Receptor, Endothelin A; Receptor, Endothelin B; Transforming Growth Factor beta1; Wound Healing | 2007 |